Shilpa Biologics permitted to conduct Phase 1 study on NavAlbumin
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
The consortium envisages carrying out surveillance of important bacterial, viral and parasitic infections of zoonotic as well as transboundary pathogens
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
Its DirectDetect reagent eliminates RNA extraction for rapid deployment of Covid-19 tests in affected countries
Barbara Engelhardt moves her computational and statistics lab to Gladstone
The trial will be conducted across 10 sites in India
The vaccine is designed to neutralise the virus in the nostril itself and prevent it from penetrating deep down into the respiratory tract
The aim is to give a fillip to R&D in the health sector to face the Covid-19 challenge
CDSCO gives the green signal as HGCO19 was safe, tolerable and immunogenic in the participants of the study
Subscribe To Our Newsletter & Stay Updated